Terms: = Breast cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
20 results:
1. Long-Term Risk of Being Bedridden in Elderly Patients Who Underwent Oncologic Surgery: A Retrospective Study Using a Japanese Claims Database.
Konishi T; Sasabuchi Y; Matsui H; Tanabe M; Seto Y; Yasunaga H
Ann Surg Oncol; 2023 Aug; 30(8):4604-4612. PubMed ID: 37149549
[TBL] [Abstract] [Full Text] [Related]
2. Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in breast cancer.
Yi W; Shen H; Sun D; Xu Y; Feng Y; Li D; Wang C
Med Sci Monit; 2021 Dec; 27():e934522. PubMed ID: 34880202
[TBL] [Abstract] [Full Text] [Related]
3. A new insight to deformability correlation of circulating tumor cells with metastatic behavior by application of a new deformability-based microfluidic chip.
Hakim M; Khorasheh F; Alemzadeh I; Vossoughi M
Anal Chim Acta; 2021 Nov; 1186():339115. PubMed ID: 34756251
[TBL] [Abstract] [Full Text] [Related]
4. A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
Lan T; Liu W; Lu Y; Luo H
Medicine (Baltimore); 2021 Apr; 100(14):e25305. PubMed ID: 33832101
[TBL] [Abstract] [Full Text] [Related]
5. Role of marital status on the prognosis in esophagus adenocarcinoma: a real-world competing risk analysis.
Lan T; Liu W; Lu Y; Zheng R; Luo H; Shao X; He J
Future Oncol; 2020 Dec; 16(35):2923-2937. PubMed ID: 32892636
[No Abstract] [Full Text] [Related]
6. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract] [Full Text] [Related]
7. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.
Mizrak Kaya D; Dong X; Nogueras-González GM; Xu Y; Estrella JS; Harada K; Lopez A; Amlashi FG; Hofstetter WL; Maru DM; Nguyen QN; Lee JH; Weston B; Bhutani MS; Erasmus JJ; Thomas I; Rogers JE; Song S; Ajani JA
Med Oncol; 2017 Aug; 34(8):135. PubMed ID: 28685276
[TBL] [Abstract] [Full Text] [Related]
8. Down-regulation of the Tumor Suppressor cyld Enhances the Transformed Phenotype of Human breast cancer Cells.
Orfanidou T; Xanthopoulos K; Dafou D; Pseftogas A; Hadweh P; Psyllaki C; Hatzivassiliou E; Mosialos G
Anticancer Res; 2017 Jul; 37(7):3493-3503. PubMed ID: 28668838
[TBL] [Abstract] [Full Text] [Related]
9. A survey on fertility management in young women of reproductive age treated with chemotherapy.
Abe A; Kuwahara A; Iwasa T; Nishimura M; Irahara M
Int J Clin Oncol; 2016 Dec; 21(6):1183-1190. PubMed ID: 27402102
[TBL] [Abstract] [Full Text] [Related]
10. Clinical significance of cyld downregulation in breast cancer.
Hayashi M; Jono H; Shinriki S; Nakamura T; Guo J; Sueta A; Tomiguchi M; Fujiwara S; Yamamoto-Ibusuki M; Murakami K; Yamashita S; Yamamoto Y; Li JD; Iwase H; Ando Y
Breast Cancer Res Treat; 2014 Feb; 143(3):447-57. PubMed ID: 24398777
[TBL] [Abstract] [Full Text] [Related]
11. Recent developments in esophageal adenocarcinoma.
Lagergren J; Lagergren P
CA Cancer J Clin; 2013; 63(4):232-48. PubMed ID: 23818335
[TBL] [Abstract] [Full Text] [Related]
12. Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Samrao D; Liu S; DuPont NC; Pejovic T
Gynecol Oncol; 2013 Jul; 130(1):174-80. PubMed ID: 23578537
[TBL] [Abstract] [Full Text] [Related]
13. The role of HDAC6 in cancer.
Aldana-Masangkay GI; Sakamoto KM
J Biomed Biotechnol; 2011; 2011():875824. PubMed ID: 21076528
[TBL] [Abstract] [Full Text] [Related]
14. [prognosis of patients with breast cancer related to the timing of operation during menstrual cycle: a report of 218 patients].
Zhang B; Shao Y; Wang C
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):203-7. PubMed ID: 9387255
[TBL] [Abstract] [Full Text] [Related]
15. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor.
DiGiovanna MP; Stern DF
Cancer Res; 1995 May; 55(9):1946-55. PubMed ID: 7728765
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
Berchuck A; Kamel A; Whitaker R; Kerns B; Olt G; Kinney R; Soper JT; Dodge R; Clarke-Pearson DL; Marks P
Cancer Res; 1990 Jul; 50(13):4087-91. PubMed ID: 1972347
[TBL] [Abstract] [Full Text] [Related]
17. Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer.
Hacene K; Desplaces A; Brunet M; Lidereau R; Bourguignat A; Oglobine J
Cancer; 1986 Jan; 57(2):245-50. PubMed ID: 3484657
[TBL] [Abstract] [Full Text] [Related]
18. Blood lymphocyte counts with subset analysis in operable breast cancer. Relation to the extent of tumor disease and prognosis.
Rotstein S; Blomgren H; Petrini B; Wasserman J; Nilsson B; Baral E
Cancer; 1985 Sep; 56(6):1413-9. PubMed ID: 4027876
[TBL] [Abstract] [Full Text] [Related]
19. Immune functions and the prognosis of patients with solid tumours.
Nordman E; Lehto I; Toivanen A
Cancer Immunol Immunother; 1985; 20(1):38-42. PubMed ID: 3851692
[TBL] [Abstract] [Full Text] [Related]
20. [prognosis of local primary breast carcinoma under current therapy].
Mutzner F; Amgwerd R; Gessner U
Schweiz Med Wochenschr; 1977 Jul; 107(28):992-4. PubMed ID: 897642
[TBL] [Abstract] [Full Text] [Related]
